background deteriorating effect severe deficiency zz genotype lung function known role intermediate deficiency mz genotype remains uncertain objective test hypothesis mz intermediate deficiency affects pulmonary function disease design cohort study followup setting copenhagen denmark participants NUMBER adults randomly selected danish general population measurements plasma levels annual decrease fev1 airway obstruction hospitalization mortality chronic obstructive pulmonary disease copd results NUMBER participants NUMBER carried mz genotype plasma levels NUMBER lower mz heterozygotes persons mm genotype student t p NUMBER annual decrease fev1 NUMBER ml mz heterozygotes NUMBER ml persons mm genotype t p NUMBER airway obstruction NUMBER mz heterozygotes compared NUMBER mm carriers test p NUMBER logistic regression analysis adjusted age sex tobacco consumption corresponding odds ratio NUMBER ci NUMBER NUMBER incidence hospitalization mortality copd NUMBER cases NUMBER NUMBER persons mz genotype NUMBER cases NUMBER NUMBER mm genotype test p NUMBER cox regression model adjusted age sex tobacco use fev1 study entry relative risk copd outcomes persons mz genotype versus persons mm genotype NUMBER ci NUMBER NUMBER results independent s e alleles gene affected cystic fibrosis delta f508 heterozygosity conclusions mz heterozygotes slightly greater rate decrease fev1 modestly persons airway obstruction copd population large mz heterozygosity account fraction copd order NUMBER similar percentage persons copd severe rare zz genotype alpha1 antitrypsin alpha1 antitrypsin population based NUMBER year alpha1 antitrypsin alpha1 antitrypsin test test chi square person years person years log rank represented cases